2026 Q1 Portfolio Activity
In 2026 Q1, Blue Owl Capital Holdings LP maintained a portfolio of 99 distinct positions. The most significant new addition was CORVUS PHARMACEUTICALS INC, now representing 2.14% of the total fund value. They heavily accumulated shares in AKTIS ONCOLOGY INC, increasing the position by 953.8%. Conversely, Blue Owl Capital Holdings LP completely exited their position in BLACKROCK INC COM.
Position History
hover any row below to update
Loading…
Total Positions
99
Quarter
2026 Q1
Top Holding
N/A (15.2%)
Top 10 Concentration
69.3%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-50 of 99
Blue Owl Capital Holdings LP Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
N/A
AKTIS ONCOLOGY ...
|
|
Unknown | 15.20% | — |
#1
Prev: #—
|
9.5 |
—
|
3,161,348 | — |
NEW
|
3,161,348 | $56,556,516 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
LRMR
LARIMAR THERAPE...
|
Healthcare | 8.61% | 1.95% |
#2
3
Prev: #5
|
5.4 |
—
|
296,317 | 4.3% |
P
S
|
7,120,007 | $32,040,032 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ENGN
ENGENE HOLDINGS...
|
Healthcare | 8.08% | 2.27% |
#3
1
Prev: #2
|
6.7 |
—
|
1,055,416 | 31.4% |
P
S
|
4,416,353 | $30,075,364 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
NCDL
NUVEEN CHURCHIL...
|
Financial Services | 7.33% | 2.14% |
#4
1
Prev: #3
|
4.4 |
—
|
no change | no change |
P
S
|
2,143,626 | $27,266,923 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CGEM
CULLINAN THERAP...
|
Healthcare | 7.29% | 1.82% |
#5
1
Prev: #6
|
3.9 |
—
|
-441,208 | -18.8% |
P
S
|
1,909,764 | $27,137,746 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OBDC
BLUE OWL CAPITA...
|
Financial Services | 6.08% | 1.95% |
#6
2
Prev: #4
|
3.4 |
—
|
no change | no change |
P
S
|
2,045,070 | $22,618,474 | 2022 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 5.49% | 0.43% |
#7
11
Prev: #18
|
5.2 |
—
|
678,871 | 207.6% |
P
S
|
1,005,929 | $20,450,537 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CMPX
COMPASS THERAPE...
|
Healthcare | 4.18% | 1.39% |
#8
1
Prev: #7
|
2.2 |
—
|
-525,000 | -15.1% |
P
S
|
2,941,525 | $15,560,667 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CNTX
CONTEXT THERAPE...
|
Healthcare | 3.58% | 0.82% |
#9
Prev: #9
|
1.4 |
—
|
-2,343,891 | -31.5% |
P
S
|
5,089,015 | $13,333,219 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
HLLY
HOLLEY INC
|
Consumer Cyclical | 3.49% | 1.28% |
#10
2
Prev: #8
|
1.9 |
—
|
90,252 | 2.2% |
P
S
|
4,236,888 | $13,007,246 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EYPT
EYEPOINT INC
|
Healthcare | 3.16% | 0.54% |
#11
3
Prev: #14
|
4.3 |
—
|
520,000 | 132.5% |
P
S
|
912,594 | $11,763,337 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CRVS
CORVUS PHARMACE...
|
Healthcare | 2.14% | — |
#12
Prev: #—
|
4.4 |
—
|
545,000 | — |
NEW
|
545,000 | $7,973,350 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CNDT
CONDUENT INC
|
Technology | 1.73% | 0.69% |
#13
3
Prev: #10
|
1.2 |
—
|
214,173 | 4.4% |
P
S
|
5,036,595 | $6,446,842 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RARE
ULTRAGENYX PHAR...
|
Healthcare | 1.70% | 0.37% |
#14
8
Prev: #22
|
3.2 |
—
|
90,000 | 42.3% |
P
S
|
302,638 | $6,340,266 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
AQST
AQUESTIVE THERA...
|
Healthcare | 1.50% | 0.25% |
#15
14
Prev: #29
|
3.6 |
—
|
822,932 | 156.7% |
P
S
|
1,347,932 | $5,593,918 | 2024 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 1.44% | — |
#16
Prev: #—
|
4.1 |
—
|
61,455 | — |
NEW
|
61,455 | $5,344,741 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
COMPASS PATHWAY...
|
|
Unknown | 1.38% | — |
#17
Prev: #—
|
4.1 |
—
|
1,804,504 | — |
NEW
|
1,804,504 | $5,133,907 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
IMMX
IMMIX BIOPHARMA...
|
Healthcare | 1.34% | 0.39% |
#18
3
Prev: #21
|
0.5 |
—
|
-438,688 | -44.5% |
P
S
|
547,552 | $4,988,199 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
IMA
IMAGENEBIO INC
|
Healthcare | 1.29% | 0.43% |
#19
1
Prev: #20
|
2.5 |
—
|
135,552 | 16.5% |
P
S
|
959,337 | $4,796,685 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CVEO
CIVEO CORP CDA
|
Consumer Cyclical | 1.28% | 0.63% |
#20
8
Prev: #12
|
0.5 |
—
|
-190,055 | -51.3% |
P
S
|
180,475 | $4,775,369 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
LENZ
LENZ THERAPEUTI...
|
Healthcare | 1.25% | 0.18% |
#21
13
Prev: #34
|
3.5 |
—
|
356,722 | 237.8% |
P
S
|
506,722 | $4,636,506 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ELDN
ELEDON PHARMACE...
|
Healthcare | 1.18% | 0.22% |
#22
10
Prev: #32
|
0.5 |
—
|
-510,000 | -26.4% |
P
S
|
1,419,912 | $4,373,329 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
KALV
KALVISTA PHARMA...
|
Healthcare | 1.16% | 0.44% |
#23
6
Prev: #17
|
0.5 |
—
|
-145,000 | -40.3% |
P
S
|
215,000 | $4,327,950 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OVID
OVID THERAPEUTI...
|
Healthcare | 1.14% | — |
#24
Prev: #—
|
4.0 |
—
|
1,904,666 | — |
NEW
|
1,904,666 | $4,228,359 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PVLA
PALVELLA THERAP...
|
Healthcare | 1.05% | 0.32% |
#25
1
Prev: #24
|
0.4 |
—
|
-9,000 | -22.4% |
P
S
|
31,259 | $3,896,434 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
PLRX
PLIANT THERAPEU...
|
Healthcare | 1.01% | 0.27% |
#26
1
Prev: #27
|
1.4 |
—
|
no change | no change |
P
S
|
2,969,199 | $3,741,191 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
STWD
STARWOOD PPTY T...
|
Real Estate | 0.73% | — |
#27
Prev: #—
|
3.8 |
—
|
158,545 | — |
NEW
|
158,545 | $2,730,145 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ADCT
ADC THERAPEUTIC...
|
Healthcare | 0.70% | 0.22% |
#28
3
Prev: #31
|
1.3 |
—
|
no change | no change |
P
S
|
733,568 | $2,589,495 | 2022 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 0.62% | — |
#29
Prev: #—
|
3.7 |
—
|
100,000 | — |
NEW
|
100,000 | $2,299,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DELL
DELL TECHNOLOGI...
|
Technology | 0.61% | 0.51% |
#30
14
Prev: #16
|
0.2 |
—
|
-39,949 | -74.2% |
P
S
|
13,899 | $2,281,243 | 2021 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
LARIMAR THERAPE...
|
|
Unknown | 0.51% | — |
#31
Prev: #—
|
3.7 |
—
|
975,700 | — |
NEW
|
975,700 | $1,913,032 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
ORIC
ORIC PHARMACEUT...
|
Healthcare | 0.51% | 0.32% |
#32
7
Prev: #25
|
0.2 |
—
|
-365,000 | -70.9% |
P
S
|
150,000 | $1,900,500 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
SGMT
SAGIMET BIOSCIE...
|
Healthcare | 0.47% | 0.55% |
#33
20
Prev: #13
|
0.2 |
—
|
-910,000 | -73.2% |
P
S
|
333,877 | $1,744,507 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
WW
WW INTL INC
|
Healthcare | 0.35% | — |
#34
Prev: #—
|
3.6 |
—
|
95,634 | — |
NEW
|
95,634 | $1,314,011 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ENGNW
ENGENE HOLDINGS...
|
Unknown | 0.35% | 0.01% |
#35
17
Prev: #52
|
3.1 |
—
|
475,077 | 1316.0% |
P
S
|
511,177 | $1,293,278 | 2023 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
EPD
ENTERPRISE PROD...
|
Energy | 0.32% | 0.08% |
#36
3
Prev: #39
|
1.1 |
—
|
no change | no change |
P
S
|
31,290 | $1,184,014 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
FLD
FOLD HLDGS INC
|
Financial Services | 0.30% | 0.07% |
#37
3
Prev: #40
|
1.1 |
—
|
no change | no change |
P
S
|
856,632 | $1,130,754 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
OPTXW
SYNTEC OPTICS H...
|
Unknown | 0.23% | 0.01% |
#38
11
Prev: #49
|
1.1 |
—
|
no change | no change |
P
S
|
803,132 | $867,383 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
MRKR
MARKER THERAPEU...
|
Healthcare | 0.19% | 0.06% |
#39
2
Prev: #41
|
1.1 |
—
|
no change | no change |
P
S
|
554,250 | $720,525 | 2024 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
MINERALYS THERA...
|
|
Unknown | 0.16% | — |
#40
Prev: #—
|
3.6 |
—
|
200,000 | — |
NEW
|
200,000 | $590,000 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
NIOBW
NIOCORP DEVS LT...
|
Unknown | 0.14% | 0.12% |
#41
5
Prev: #36
|
0.1 |
—
|
-556,048 | -63.5% |
P
S
|
320,100 | $524,964 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
COMPASS THERAPE...
|
|
Unknown | 0.13% | — |
#42
Prev: #—
|
3.6 |
—
|
400,000 | — |
NEW
|
400,000 | $500,000 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
BNAIW
BRAND ENGAGEMEN...
|
Unknown | 0.11% | 0.01% |
#43
8
Prev: #51
|
0.0 |
—
|
-1,059,468 | -38.9% |
P
S
|
1,666,808 | $416,702 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 0.10% | 0.03% |
#44
1
Prev: #43
|
1.0 |
—
|
no change | no change |
P
S
|
1,718 | $363,031 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
RZLVW
REZOLVE AI PLC
|
Unknown | 0.05% | 0.02% |
#45
2
Prev: #47
|
0.5 |
—
|
-54,188 | -18.7% |
P
S
|
235,121 | $202,204 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
N/A
PIPER SANDLER C...
|
|
Unknown | 0.05% | — |
#46
Prev: #—
|
3.5 |
—
|
2,428 | — |
NEW
|
2,428 | $185,863 | — | 13F Filing | 2026-03-31 | 2026-05-14 | ||
|
AMOD
ALPHA MODUS HLD...
|
Technology | 0.04% | 0.01% |
#47
3
Prev: #50
|
1.0 |
—
|
no change | no change |
P
S
|
394,078 | $145,809 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
ET
ENERGY TRANSFER...
|
Energy | 0.03% | — |
#48
Prev: #—
|
3.5 |
—
|
5,326 | — |
NEW
|
5,326 | $102,792 | 2024 Q3 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
DAIC
CID HOLDCO INC
|
Technology | 0.03% | 0.02% |
#49
5
Prev: #44
|
1.0 |
—
|
no change | no change |
P
S
|
557,361 | $94,751 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-14 | |||
|
CAI
CARIS LIFE SCIE...
|
Healthcare | 0.02% | — |
#50
Prev: #—
|
3.5 |
—
|
4,711 | — |
NEW
|
4,711 | $84,233 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-14 |
Showing 1-50 of 99 holdings